These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

705 related items for PubMed ID: 8682031

  • 1. Safety of flecainide versus propafenone for the long-term management of symptomatic paroxysmal supraventricular tachyarrhythmias. Report from the Flecainide and Propafenone Italian Study (FAPIS) Group.
    Chimienti M, Cullen MT, Casadei G.
    Eur Heart J; 1995 Dec; 16(12):1943-51. PubMed ID: 8682031
    [Abstract] [Full Text] [Related]

  • 2. Safety of long-term flecainide and propafenone in the management of patients with symptomatic paroxysmal atrial fibrillation: report from the Flecainide and Propafenone Italian Study Investigators.
    Chimienti M, Cullen MT, Casadei G.
    Am J Cardiol; 1996 Jan 25; 77(3):60A-75A. PubMed ID: 8607393
    [Abstract] [Full Text] [Related]

  • 3. Safety and utility of flecainide acetate in the routine care of patients with supraventricular tachyarrhythmias: results of a multicenter trial. The Flecainide Supraventricular Tachycardia Study Group.
    Hopson JR, Buxton AE, Rinkenberger RL, Nademanee K, Heilman JM, Kienzle MG.
    Am J Cardiol; 1996 Jan 25; 77(3):72A-82A. PubMed ID: 8607395
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the safety and efficacy of flecainide versus propafenone in hospital out-patients with symptomatic paroxysmal atrial fibrillation/flutter. The Flecainide AF French Study Group.
    Aliot E, Denjoy I.
    Am J Cardiol; 1996 Jan 25; 77(3):66A-71A. PubMed ID: 8607394
    [Abstract] [Full Text] [Related]

  • 5. Placebo-controlled evaluations of propafenone for atrial tachyarrhythmias.
    Rae AP.
    Am J Cardiol; 1998 Oct 16; 82(8A):59N-65N. PubMed ID: 9809902
    [Abstract] [Full Text] [Related]

  • 6. Propafenone treatment of symptomatic paroxysmal supraventricular arrhythmias. A randomized, placebo-controlled, crossover trial in patients tolerating oral therapy.
    Pritchett EL, McCarthy EA, Wilkinson WE.
    Ann Intern Med; 1991 Apr 01; 114(7):539-44. PubMed ID: 2001087
    [Abstract] [Full Text] [Related]

  • 7. Long-term follow-up of patients with inducible supraventricular tachycardia treated with flecainide or propafenone: therapy guided by transesophageal electropharmacologic testing.
    Furlanello F, Guarnerio M, Inama G, Vergara G, Del Greco M, Bertoldi A, Dallago M.
    Am J Cardiol; 1992 Aug 20; 70(5):19A-25A. PubMed ID: 1509994
    [Abstract] [Full Text] [Related]

  • 8. A randomized comparison of flecainide versus verapamil in paroxysmal supraventricular tachycardia. The Flecainide Multicenter Investigators Group.
    Dorian P, Naccarelli GV, Coumel P, Hohnloser SH, Maser MJ.
    Am J Cardiol; 1996 Jan 25; 77(3):89A-95A. PubMed ID: 8607397
    [Abstract] [Full Text] [Related]

  • 9. A randomized, placebo-controlled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation. UK Propafenone PSVT Study Group.
    Circulation; 1995 Nov 01; 92(9):2550-7. PubMed ID: 7586356
    [Abstract] [Full Text] [Related]

  • 10. Safety and tolerability of long-term propafenone therapy for supraventricular tachyarrhythmias. The Propafenone Multicenter Study Group.
    Podrid PJ, Anderson JL.
    Am J Cardiol; 1996 Aug 15; 78(4):430-4. PubMed ID: 8752188
    [Abstract] [Full Text] [Related]

  • 11. Flecainide acetate treatment of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation: dose-response studies. The Flecainide Supraventricular Tachycardia Study Group.
    Pritchett EL, DaTorre SD, Platt ML, McCarville SE, Hougham AJ.
    J Am Coll Cardiol; 1991 Feb 15; 17(2):297-303. PubMed ID: 1899432
    [Abstract] [Full Text] [Related]

  • 12. [Electropharmacological test with class-I C drugs in paroxysmal supraventricular re-entrant tachycardia: is a negative result with a drug predictive of the ineffectiveness of other drugs of the same class?].
    Inama G, Furlanello F, Braito G, Guarnerio M, Vergara G.
    G Ital Cardiol; 1991 Feb 15; 21(2):131-8. PubMed ID: 1907937
    [Abstract] [Full Text] [Related]

  • 13. Flecainide for supraventricular tachyarrhythmias.
    Med Lett Drugs Ther; 1992 Jul 24; 34(875):71-2. PubMed ID: 1630411
    [No Abstract] [Full Text] [Related]

  • 14. Flecainide acetate for paroxysmal supraventricular tachyarrhythmias. The Flecainide Supraventricular Tachycardia Study Group.
    Anderson JL, Platt ML, Guarnieri T, Fox TL, Maser MJ, Pritchett EL.
    Am J Cardiol; 1994 Sep 15; 74(6):578-84. PubMed ID: 8074041
    [Abstract] [Full Text] [Related]

  • 15. Long-term safety and efficacy of flecainide in the treatment of supraventricular tachyarrhythmias: the United States experience. The Flecainide Supraventricular Tachyarrhythmia Investigators.
    Anderson JL.
    Am J Cardiol; 1992 Aug 20; 70(5):11A-17A; discussion 17A-18A. PubMed ID: 1509993
    [Abstract] [Full Text] [Related]

  • 16. Comparisons of oral propafenone and quinidine as an initial treatment option in patients with symptomatic paroxysmal atrial fibrillation: a double-blind, randomized trial.
    Lee SH, Chen SA, Chiang CE, Tai CT, Wen ZC, Wang SP, Chang MS.
    J Intern Med; 1996 Mar 20; 239(3):253-60. PubMed ID: 8772625
    [Abstract] [Full Text] [Related]

  • 17. Correlation of symptoms with occurrence of paroxysmal supraventricular tachycardia or atrial fibrillation: a transtelephonic monitoring study. The Flecainide Supraventricular Tachycardia Study Group.
    Bhandari AK, Anderson JL, Gilbert EM, Alpert BL, Henthorn RW, Waldo AL, Cullen MT, Hawkinson RW, Pritchett EL.
    Am Heart J; 1992 Aug 20; 124(2):381-6. PubMed ID: 1636582
    [Abstract] [Full Text] [Related]

  • 18. Long term evaluation of flecainide acetate in supraventricular tachyarrhythmias.
    Mary-Rabine L, Telerman M.
    Acta Cardiol; 1988 Aug 20; 43(1):37-48. PubMed ID: 3132008
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of long-term oral flecainide acetate in patients with responsive supraventricular tachycardia.
    Hellestrand KJ.
    Am J Cardiol; 1996 Jan 25; 77(3):83A-88A. PubMed ID: 8607396
    [Abstract] [Full Text] [Related]

  • 20. [The efficacy of propafenon in the case of supraventricular atrioventricular tachycardia].
    Chachua T, Abuladze G, Nebieridze M.
    Georgian Med News; 2010 Jun 25; (183):18-21. PubMed ID: 20622270
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.